Feed IXC.AX
IX
Invex Therapeutics Ltd
IXC.AX · ASX
$0.12 +0.00% (+$0.00)
1M +15.00%
Market Cap $8.6M
P/E Ratio -
Div. Yield -
ROE 8.82%
Bulios Fair Price
$0.07
39.1% downside
Preț actual
$0.12
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile IXC.AX sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
48 /100
Fair P/B 1.65x
P/S 37.73x
EV/FFO N/A
Growth
45 /100
Stable Book val. growth 43.10%
Rev. growth 7.92%
FCF growth N/A
Profitability
20 /100
Weak Net margin 208.16%
Op. margin 309.63%
FCF margin 284.86%
Quality
0 /100
Poor ROE 8.82%
ROA 8.72%
Asset turnover 0.04x
Debt
100 /100
Low Current ratio 24.79x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
22 /100
Unstable Rev. volatility 138.15%
EPS volatility 95.19%
Profitable years 0
Întreabă StockBot despre IXC.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Timothy Ryan Slate
Employees
4
Headquarters
Subiaco
Evenimente viitoare
13 AUG.
Earnings
Upcoming earnings report